Search

Displaying results 141 - 150 of 4822 in total
  1. Drug

    Titanium dioxide

    go.drugbank.com/drugs/DB09536
    Approved

    It is used as a pigment under the names titanium white, Pigment White 6 (PW6), or CI 77891. It is typically extracted from ilmenite, rutile and anatase.

    Mixtures: Luxe Art Beaute SAS (69879-108-35) Cover-Expert Sunscreen Broad Spectrum SPF 15 No.8 Intense Beige, 35ml, TONYMOLY Face Mix Skin Makeup Base 02 Mix Lavendar SPF20Products: Myung Han Mi In Do Makeup Base Spf20 Pa 01 Green, Myung Han Mi In Do Foundation Spf20 Pa Nb21
  2. Drug

    Olopatadine

    go.drugbank.com/drugs/DB00768
    Approved

    It is a structural analog of [doxepin], which has a minimal anti-allergic activity. … It is currently marketed under several brand names, including Pazeo, Patanase, and Opatanol.

    Products: Mint-olopatadine, Mint-olopatadine 0.2%
  3. Drug

    Valganciclovir

    go.drugbank.com/drugs/DB01610
    ApprovedInvestigational

    As the L-valyl ester of ganciclovir, it is actually a prodrug for ganciclovir. After oral administration, it is rapidly converted to ganciclovir by intestinal and hepatic esterases.

    Products: Mint-valganciclovir
  4. Drug

    Panthenol

    go.drugbank.com/drugs/DB11204
    Approved

    Furthermore, it acts as a topical protectant, moisturizer, and has demonstrated anti-inflammatory properties [A32377].

    Products: bdr Protect ultra hydrating anti-pollution skin defense mist
  5. Drug

    Icatibant

    go.drugbank.com/drugs/DB06196
    ApprovedInvestigational

    It is resistant to bradykinin-cleaving enzyme degradation and has a potency of 2-3 times higher than earlier B<sub>2</sub> receptors antagonists, thus representing a new class of medication. … [A4017,A263041] It was investigated as a potential treatment of hereditary angioedema (HAE) as bradykinin was implicated in HAE swelling; specifically, mice lacking B<sub>2</sub> receptors showed reduced

    Products: Mint-icatibant
  6. Drug

    Daptomycin

    go.drugbank.com/drugs/DB00080
    ApprovedInvestigational

    [A231384] Early work on developing daptomycin was abandoned due to observed myopathy but was resumed in 1997 when Cubist Pharmaceuticals Inc. licensed daptomycin; it was found that a once-daily dosing

    Products: Daptomycin MIP 350 mg Pulver zur Herstellung einer Injektions-/Infusionslösung, Daptomycin MIP 500 mg Pulver zur Herstellung einer Injektions-/Infusionslösung
  7. Drug

    Cefepime

    go.drugbank.com/drugs/DB01413
    ApprovedInvestigational

    Cefepime is a fourth-generation cephalosporin antibiotic developed in 1994. Cefepime is active against Gram-positive and Gram-negative bacteria, and has greater activity against both compared to third-generation antibiotics. Cefepime is ...

    Products: Cefepim-MIP 1 g Pulver zur Herstellung einer Injektions-/Infusionslösung, Cefepim-MIP 2 g Pulver zur Herstellung einer Injektions-/Infusionslösung
  8. Drug

    QXL138AM

    go.drugbank.com/drugs/DB18552
    Investigational

    QXL138AM is a masked immunocytokine (MIC) comprised of an anti-CD138 immunoglobulin G1 antibody fused to interferon alpha 2a. It binds the CD138 protein on the surface of the tumour cells.

    Synonyms: Masked immunocytokine (MIC) comprised of an anti-CD138 immunoglobulin G1 antibody fused to interferon alpha 2a
  9. Drug

    Sotalol

    go.drugbank.com/drugs/DB00489
    ApprovedInvestigational

    [A178579] It was the first of the class III anti arrhythmic drugs.[A178579] Sotalol was first approved as an oral tablet on 30 October 1992.

    International brands: Darob miteProducts: SOTALEX 80 MG MITE
  10. Drug

    Atenolol

    go.drugbank.com/drugs/DB00335
    ApprovedInvestigational

    Atenolol is a cardioselective beta-blocker used in a variety of cardiovascular conditions. Sir James Black, a Scottish pharmacologist, pioneered the use of beta-blockers for the management of angina pectoris in 1958 for which he received...

    Mixtures: ATENOLOL AL COMP MITE, ATENOLOL AL COMP MITEProducts: MIN-T, Mint-atenol